window.figureList = [

    // =======================
    // MultiVelo · Main Figures
    // =======================
  
    {
      id: "multivelo-fig1",
      file: "images/figures/MultiVelo/Fig1.png",
      badge: "Fig 1",
      venue: "Nature Biotechnology",
      topic: "Multi-omics modeling",
      tagPrimary: "Nature Biotechnolo g y",
      tagSecondary: "Model schematic",
      titleShort: "Fig 1 · Model overview",
      titleFull: "Nature Biotechnology 2023 · Schematic of MultiVelo",
      meta: "Nature Biotechnology · Fig. 1 · Overview of MultiVelo and gene state model",
      desc: "ODE model, chromatin/RNA dynamics, priming & decoupling.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-fig2",
      file: "images/figures/MultiVelo/Fig2.png",
      badge: "Fig 2",
      venue: "Nature Biotechnology",
      topic: "Velocity analysis",
      tagPrimary: "Nature Biotechnology",
      tagSecondary: "Gene dynamics",
      titleShort: "Fig 2 · Gene dynamics",
      titleFull: "Nature Biotechnology 2023 · Gene regulation models",
      meta: "Nature Biotechnology · Fig. 2 · Model 1 vs model 2 gene dynamics",
      desc: "UMAP velocities, phase portraits, model 1/2 comparison.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-fig3",
      file: "images/figures/MultiVelo/Fig3.png",
      badge: "Fig 3",
      venue: "Nature Biotechnology",
      topic: "Epigenomic regulation",
      tagPrimary: "Nature Biotechnology",
      tagSecondary: "Neurodevelopment",
      titleShort: "Fig 3 · Brain priming",
      titleFull: "Nature Biotechnology 2023 · Priming in embryonic brain",
      meta: "Nature Biotechnology · Fig. 3 · Priming & decoupling across neural lineages",
      desc: "Priming, decoupling and lineage time-course patterns.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-fig4",
      file: "images/figures/MultiVelo/Fig4.png",
      badge: "Fig 4",
      venue: "Nature Biotechnology",
      topic: "SHARE-seq",
      tagPrimary: "Nature Biotechnology",
      tagSecondary: "Hair follicle",
      titleShort: "Fig 4 · Skin priming",
      titleFull: "Nature Biotechnology 2023 · Skin / hair follicle dynamics",
      meta: "Nature Biotechnology · Fig. 4 · TAC → IRS differentiation",
      desc: "Chromatin priming in TAC/IRS lineages.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-fig5",
      file: "images/figures/MultiVelo/Fig5.png",
      badge: "Fig 5",
      venue: "Nature Biotechnology",
      topic: "Blood development",
      tagPrimary: "Nature Biotechnology",
      tagSecondary: "Hematopoiesis",
      titleShort: "Fig 5 · HSPC priming",
      titleFull: "Nature Biotechnology 2023 · Human HSPCs",
      meta: "Nature Biotechnology · Fig. 5 · Hematopoietic differentiation",
      desc: "Lineage-specific epigenomic priming in hematopoiesis.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-fig6",
      file: "images/figures/MultiVelo/Fig6.png",
      badge: "Fig 6",
      venue: "Nature Biotechnology",
      topic: "TF regulation",
      tagPrimary: "Nature Biotechnology",
      tagSecondary: "Fetal brain",
      titleShort: "Fig 6 · TF timing",
      titleFull: "Nature Biotechnology 2023 · Fetal cortex TF/SNP timing",
      meta: "Nature Biotechnology · Fig. 6 · TF motif accessibility and SNP timing",
      desc: "TF expression vs motif accessibility; GWAS SNP timing.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    // =======================
    // MultiVelo · Extended Figures
    // =======================
  
    {
      id: "multivelo-extfig1",
      file: "images/figures/MultiVelo/Ext-Fig1.png",
      badge: "Ext 1",
      venue: "Nature Biotechnology",
      topic: "Gene kinetics",
      tagPrimary: "Extended data",
      tagSecondary: "Priming / decoupling",
      titleShort: "Ext Fig 1",
      titleFull: "Nature Biotechnology 2023 · Extended Fig. 1",
      meta: "Nature Biotechnology · Extended Fig. 1 · Priming & decoupling intervals",
      desc: "Ranking of priming and decoupling durations.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-extfig2",
      file: "images/figures/MultiVelo/Ext-Fig2.png",
      badge: "Ext 2",
      venue: "Nature Biotechnology",
      topic: "Data QC",
      tagPrimary: "Extended data",
      tagSecondary: "HSPC",
      titleShort: "Ext Fig 2",
      titleFull: "Nature Biotechnology 2023 · Extended Fig. 2",
      meta: "Nature Biotechnology · Extended Fig. 2 · HSPC dataset QC",
      desc: "QC metrics and clustering for HSPCs.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-extfig3",
      file: "images/figures/MultiVelo/Ext-Fig3.png",
      badge: "Ext 3",
      venue: "Nature Biotechnology",
      topic: "TF dynamics",
      tagPrimary: "Extended data",
      tagSecondary: "TF motifs",
      titleShort: "Ext Fig 3",
      titleFull: "Nature Biotechnology 2023 · Extended Fig. 3",
      meta: "Nature Biotechnology · Extended Fig. 3 · TF–motif timing examples",
      desc: "Additional TF–motif alignment examples.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-extfig4",
      file: "images/figures/MultiVelo/Ext-Fig4.png",
      badge: "Ext 4",
      venue: "Nature Biotechnology",
      topic: "Model validation",
      tagPrimary: "Extended data",
      tagSecondary: "Chromatin kinetics",
      titleShort: "Ext Fig 4",
      titleFull: "Nature Biotechnology 2023 · Extended Fig. 4",
      meta: "Nature Biotechnology · Extended Fig. 4 · Chromatin kinetics simulation",
      desc: "Simulated chromatin opening/closing dynamics.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
  
    {
      id: "multivelo-extfig5",
      file: "images/figures/MultiVelo/Ext-Fig5.png",
      badge: "Ext 5",
      venue: "Nature Biotechnology",
      topic: "Performance",
      tagPrimary: "Extended data",
      tagSecondary: "Benchmark",
      titleShort: "Ext Fig 5",
      titleFull: "Nature Biotechnology 2023 · Extended Fig. 5",
      meta: "Nature Biotechnology · Extended Fig. 5 · Benchmark and runtime",
      desc: "Runtime, memory usage, performance benchmarks.",
      paperId: "natbiotech-2023-multivelo",
      paperTitle: "2023 · Multi-omic single-cell velocity models epigenome–transcriptome interactions and improves cell fate prediction"
    },
    {
      id: "squidiff-fig1",
      file: "images/figures/Squidiff/Fig1.png",
      badge: "Fig 1",
      venue: "Nature Methods",
      topic: "Diffusion model",
      tagPrimary: "Nature Methods",
      tagSecondary: "Model overview",
      titleShort: "Fig 1 · Framework overview",
      titleFull: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model framework and synthetic data",
      meta: "Nature Methods · Fig. 1 · Overview of Squidiff architecture and synthetic demonstration of latent diffusion and interpolation.",
      desc: "Waddington landscape, semantic encoder + conditional DDIM, latent diffusion and interpolation on synthetic cell types.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },
  
    {
      id: "squidiff-fig2",
      file: "images/figures/Squidiff/Fig2.png",
      badge: "Fig 2",
      venue: "Nature Methods",
      topic: "Cell differentiation",
      tagPrimary: "Nature Methods",
      tagSecondary: "iPSC to endoderm",
      titleShort: "Fig 2 · iPSC differentiation",
      titleFull: "Nature Methods 2026 · Predicting iPSC differentiation to definitive endoderm",
      meta: "Nature Methods · Fig. 2 · Squidiff prediction of iPSC → mesendoderm → definitive endoderm and comparison with scGen/trajectory methods.",
      desc: "Interpolated days 1–3, NANOG/GATA6/T dynamics, pseudotime reconstruction and benchmarking vs scGen and PAGA/Monocle/Scorpius.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },
  
    {
      id: "squidiff-fig3",
      file: "images/figures/Squidiff/Fig3.png",
      badge: "Fig 3",
      venue: "Nature Methods",
      topic: "Perturbation modeling",
      tagPrimary: "Nature Methods",
      tagSecondary: "Gene & drug response",
      titleShort: "Fig 3 · Perturbation prediction",
      titleFull: "Nature Methods 2026 · Gene and drug perturbation predictions",
      meta: "Nature Methods · Fig. 3 · Two-gene nonadditive perturbations, drug-response prediction and integration with rFCFP for unseen compounds.",
      desc: "ZBTB25+PTPN12 nonadditive perturbation, glioblastoma drug screen, and rFCFP adaptor enabling unseen-compound prediction vs PRnet.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },
  
    {
      id: "squidiff-fig4",
      file: "images/figures/Squidiff/Fig4.png",
      badge: "Fig 4",
      venue: "Nature Methods",
      topic: "Organoid development",
      tagPrimary: "Nature Methods",
      tagSecondary: "Vessel organoids",
      titleShort: "Fig 4 · BVO differentiation",
      titleFull: "Nature Methods 2026 · Blood vessel organoid lineage differentiation",
      meta: "Nature Methods · Fig. 4 · Squidiff-predicted trajectories from iPSCs to endothelial, mural and fibroblast lineages in vessel organoids.",
      desc: "Interpolated BVO development, endothelial/mural/fibroblast marker dynamics and mural progenitors giving rise to EC-like states.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },
  
    {
      id: "squidiff-fig5",
      file: "images/figures/Squidiff/Fig5.png",
      badge: "Fig 5",
      venue: "Nature Methods",
      topic: "Radiation response",
      tagPrimary: "Nature Methods",
      tagSecondary: "Neutron irradiation",
      titleShort: "Fig 5 · Radiation damage",
      titleFull: "Nature Methods 2026 · Neutron irradiation disrupts vessel organoids",
      meta: "Nature Methods · Fig. 5 · Structural and metabolic changes in BVOs after neutron irradiation and Squidiff-predicted irradiated transcriptomes.",
      desc: "Workflow, control vs irradiated UMAPs, DE genes (CDKN1A, MDM2, GDF15, etc.), cytokine ELISA and CD31/α-SMA imaging of damaged vasculature.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },
  
    {
      id: "squidiff-fig6",
      file: "images/figures/Squidiff/Fig6.png",
      badge: "Fig 6",
      venue: "Nature Methods",
      topic: "Radioprotection",
      tagPrimary: "Nature Methods",
      tagSecondary: "G-CSF treatment",
      titleShort: "Fig 6 · G-CSF rescue",
      titleFull: "Nature Methods 2026 · G-CSF mitigates irradiation-induced damage in BVOs",
      meta: "Nature Methods · Fig. 6 · G-CSF signaling pathways and Squidiff-predicted cell-type-specific rescue effects in irradiated vessel organoids.",
      desc: "G-CSF → MEK/ERK, PI3K–AKT, NF-κB schematic; UMAP of healthy/irradiated/G-CSF cells; GO terms for fibroblast/EC responses and reduced apoptosis.",
      paperId: "natmethods-2026-squidiff",
      paperTitle: "2026 · Squidiff: predicting cellular development and responses to perturbations using a diffusion model"
    },

    {
      id: "inflammation-fig1",
      file: "images/figures/Inflammation/Fig1.png",
      badge: "Fig 1",
      venue: "Nature Medicine",
      topic: "Atlas overview",
      tagPrimary: "Atlas",
      tagSecondary: "Cell states",
      titleShort: "Fig 1 · Inflammation atlas",
      titleFull: "Nature Medicine 2026 · Fig. 1",
      meta: "Nature Medicine 2026 · Fig. 1 · Overview of the inflammation atlas of circulating immune cells across diseases.",
      desc: "Study design, dataset composition, UMAP of major lineages and disease groups, and Sankey-style annotation of 64 immune cell states.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-fig2",
      file: "images/figures/Inflammation/Fig2.png",
      badge: "Fig 2",
      venue: "Nature Medicine",
      topic: "Inflammation signatures",
      tagPrimary: "Gene signatures",
      tagSecondary: "STAT1/SP1 programs",
      titleShort: "Fig 2 · Signature landscape",
      titleFull: "Nature Medicine 2026 · Fig. 2",
      meta: "Nature Medicine 2026 · Fig. 2 · Inflammation-related gene signatures across cell types and diseases.",
      desc: "Spectra-derived inflammation signatures and STAT1/SP1 transcription factor activities highlighting shared and disease-specific IFN and TNF signaling programs.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-fig3",
      file: "images/figures/Inflammation/Fig3.png",
      badge: "Fig 3",
      venue: "Nature Medicine",
      topic: "Interpretable ML",
      tagPrimary: "d-SHAP features",
      tagSecondary: "Disease classifiers",
      titleShort: "Fig 3 · Gene discovery",
      titleFull: "Nature Medicine 2026 · Fig. 3",
      meta: "Nature Medicine 2026 · Fig. 3 · Functional gene discovery using interpretable machine learning.",
      desc: "XGBoost-based disease classifiers with d-SHAP feature importance, showing confusion matrices, performance with top-ranked genes, and CYBA/IFITM1 case studies across diseases and cell types.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-fig4",
      file: "images/figures/Inflammation/Fig4.png",
      badge: "Fig 4",
      venue: "Nature Medicine",
      topic: "Patient classifier pipeline",
      tagPrimary: "Pipeline",
      tagSecondary: "Cross-validation",
      titleShort: "Fig 4 · Classifier pipeline",
      titleFull: "Nature Medicine 2026 · Fig. 4",
      meta: "Nature Medicine 2026 · Fig. 4 · Schematic representation of the patient classifier pipeline and performance evaluation.",
      desc: "Overview of the patient classifier workflow and three evaluation scenarios, with WF1 distributions, F1 per disease–cell-type pair, and confusion matrices across scenarios.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-fig5",
      file: "images/figures/Inflammation/Fig5.png",
      badge: "Fig 5",
      venue: "Nature Medicine",
      topic: "Centralized benchmarking",
      tagPrimary: "Classifier performance",
      tagSecondary: "Integration methods",
      titleShort: "Fig 5 · Centralized performance",
      titleFull: "Natur e Medicine 2026 · Fig. 5",
      meta: "Nature Medicine 2026 · Fig. 5 · Evaluating patient classifier performance on a Centralized Dataset and comparing integration approaches.",
      desc: "WF1 and F1 scores plus confusion matrices for a centralized dataset, and benchmarking of scANVI against Harmony+Symphony, scGen and scPoli embeddings in Scenarios 2 and 3.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig1",
      file: "images/figures/Inflammation/Ext-Fig1.png",
      badge: "Ext 1",
      venue: "Nature Medicine",
      topic: "Atlas composition",
      tagPrimary: "Cohort overview",
      tagSecondary: "Batch metrics",
      titleShort: "Ext Fig 1 · Atlas composition",
      titleFull: "Nature Medicine 2026 · Extended Fig. 1",
      meta: "Nature Medicine 2026 · Extended Fig. 1 · Composition and technical evaluation of the inflammation atlas datasets.",
      desc: "Patient counts across diseases with technical and clinical metadata, scIB metrics across embeddings, confounder R² heatmaps, and compositional shifts of major immune lineages.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig2",
      file: "images/figures/Inflammation/Ext-Fig2.png",
      badge: "Ext 2",
      venue: "Nature Medicine",
      topic: "TF-based signatures",
      tagPrimary: "TF activity",
      tagSecondary: "IFN signatures",
      titleShort: "Ext Fig 2 · STAT1/SP1",
      titleFull: "Nature Medicine 2026 · Extended Fig. 2",
      meta: "Nature Medicine 2026 · Extended Fig. 2 · Inflammation-related signatures across diseases and cell types with STAT1/SP1 programs.",
      desc: "STAT1 and SP1 transcription factor activity across diseases and immune subsets, with boxplots of pseudobulk TF activity and disease-specific patterns in SLE, Flu, cirrhosis and HNSCC.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig3",
      file: "images/figures/Inflammation/Ext-Fig3.png",
      badge: "Ext 3",
      venue: "Nature Medicine",
      topic: "Cell-type classifiers",
      tagPrimary: "Confusion matrices",
      tagSecondary: "Prediction errors",
      titleShort: "Ext Fig 3 · Cell-wise confusion",
      titleFull: "Nature Medicine 2026 · Extended Fig. 3",
      meta: "Nature Medicine 2026 · Extended Fig. 3 · Confusion matrices of predicted inflammatory condition by cell type.",
      desc: "Per–cell type confusion matrices for disease prediction using XGBoost trained on scANVI-corrected versus uncorrected expression profiles, highlighting misclassification patterns.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig4",
      file: "images/figures/Inflammation/Ext-Fig4.png",
      badge: "Ext 4",
      venue: "Nature Medicine",
      topic: "COMBAT misclassification",
      tagPrimary: "Dataset bias",
      tagSecondary: "Clustering",
      titleShort: "Ext Fig 4 · COMBAT errors",
      titleFull: "Nature Medicine 2026 · Extended Fig. 4",
      meta: "Nature Medicine 2026 · Extended Fig. 4 · Exploring cell misclassification within the COMBAT2022 dataset.",
      desc: "Confusion matrices and hierarchical clustering analyses showing misclassification structure and batch/disease covariates in the COMBAT2022 cohort.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig5",
      file: "images/figures/Inflammation/Ext-Fig5.png",
      badge: "Ext 5",
      venue: "Nature Medicine",
      topic: "Sex-stratified performance",
      tagPrimary: "Sex differences",
      tagSecondary: "Classifier metrics",
      titleShort: "Ext Fig 5 · Sex-specific metrics",
      titleFull: "Nature Medicine 2026 · Extended Fig. 5",
      meta: "Nature Medicine 2026 · Extended Fig. 5 · Sex-specific classification performances.",
      desc: "Cell-wise and patient-wise classifier performance stratified by sex, showing confusion matrices and WF1 distributions for male versus female patients across scenarios.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig6",
      file: "images/figures/Inflammation/Ext-Fig6.png",
      badge: "Ext 6",
      venue: "Nature Medicine",
      topic: "Biomarker discovery",
      tagPrimary: "Feature ranking",
      tagSecondary: "d-SHAP vs s-SHAP",
      titleShort: "Ext Fig 6 · Biomarkers",
      titleFull: "Nature Medicine 2026 · Extended Fig. 6",
      meta: "Nature Medicine 2026 · Extended Fig. 6 · Functional biomarker discovery using interpretable machine learning.",
      desc: "Ranked gene lists, d-SHAP importance maps and d-SHAP vs s-SHAP scatter plots for CYBA and IFITM1 across diseases and cell types, highlighting robust biomarker candidates.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig7",
      file: "images/figures/Inflammation/Ext-Fig7.png",
      badge: "Ext 7",
      venue: "Nature Medicine",
      topic: "Extended workflow",
      tagPrimary: "Pipeline schema",
      tagSecondary: "Reference/query design",
      titleShort: "Ext Fig 7 · Workflow schema",
      titleFull: "Nature Medicine 2026 · Extended Fig. 7",
      meta: "Nature Medicine 2026 · Extended Fig. 7 · Extended patient classifier workflow schema.",
      desc: "Detailed schematic of reference and query dataset definitions, scANVI integration and mapping, classifier hyperparameter tuning and evaluation across all scenarios.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig8",
      file: "images/figures/Inflammation/Ext-Fig8.png",
      badge: "Ext 8",
      venue: "Nature Medicine",
      topic: "Scenario 1 metrics",
      tagPrimary: "Performance metrics",
      tagSecondary: "Cross-validation",
      titleShort: "Ext Fig 8 · Scenario 1",
      titleFull: "Nature Medicine 2026 · Extended Fig. 8",
      meta: "Nature Medicine 2026 · Extended Fig. 8 · Additional performance evaluation metrics in Scenario 1.",
      desc: "Boxplots of balanced accuracy, F1, precision, recall and Matthews correlation coefficients plus recall/precision heatmaps for five-fold cross-validation in Scenario 1.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig9",
      file: "images/figures/Inflammation/Ext-Fig9.png",
      badge: "Ext 9",
      venue: "Nature Medicine",
      topic: "Centralized metrics",
      tagPrimary: "Centralized dataset",
      tagSecondary: "Integration comparison",
      titleShort: "Ext Fig 9 · Centralized metrics",
      titleFull: "Nature Medicine 2026 · Extended Fig. 9",
      meta: "Nature Medicine 2026 · Extended Fig. 9 · Additional performance metrics in the centralized dataset and across integration methods.",
      desc: "Balanced accuracy and Matthews correlation for centralized left-out pools, plus recall/precision heatmaps and weighted recall/precision distributions across integration approaches.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    
    {
      id: "inflammation-extfig10",
      file: "images/figures/Inflammation/Ext-Fig10.png",
      badge: "Ext 10",
      venue: "Nature Medicine",
      topic: "Generalization benchmarking",
      tagPrimary: "Scenarios 2 & 3",
      tagSecondary: "Integration benchmarking",
      titleShort: "Ext Fig 10 · Scenarios 2 & 3",
      titleFull: "Nature Medicine 2026 · Extended Fig. 10",
      meta: "Nature Medicine 2026 · Extended Fig. 10 · Patient classifier performance in Scenarios 2 and 3.",
      desc: "WF1 point plots, F1 heatmaps and confusion matrices for patients from unseen cohorts and studies, benchmarking multiple integration and mapping methods against random baselines.",
      paperId: "natmed-2026-inflammation",
      paperTitle: "2026 · Interpretable inflammation landscape of circulating immune cells"
    },
    


  ];
  